|
Market Closed -
OTC Markets
21:31:55 26/05/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.3800 USD | -28.30% |
|
-28.27% | -15.56% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.88M 1.77M 1.61M 3.03M 207M 3.07M 20.77M 8.12M 104M 8.17M 7.99M 346M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.68M 10.94M 9.98M 18.77M 1.29B 19.06M 129M 50.32M 644M 50.62M 49.52M 2.15B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -28.30% | ||
| 1 week | -28.27% | ||
| Current month | -28.27% | ||
| 1 month | -28.29% | ||
| 3 months | -30.91% | ||
| 6 months | -13.64% | ||
| Current year | -15.56% |
| 1 week | 0.38 |  | 0.53 |
| 1 month | 0.38 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.23 | | 0.57 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/9/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -28.30% | -28.27% | +6.15% | -56.06% | 3.33M | |
| +0.43% | +4.31% | +90.84% | +130.99% | 1,083B | |
| +0.41% | +1.27% | +50.98% | +50.05% | 626B | |
| -0.53% | +1.04% | +25.23% | +63.46% | 442B | |
| -0.92% | +0.22% | +48.34% | +37.85% | 363B | |
| -1.32% | -0.21% | +29.07% | +36.81% | 295B | |
| -1.20% | -2.78% | +5.56% | +6.09% | 248B | |
| +0.45% | +2.05% | +46.04% | +58.54% | 224B | |
| -2.51% | +1.77% | -6.55% | -51.74% | 210B | |
| +0.07% | +3.12% | +13.21% | +69.84% | 168B | |
| Average | -3.34% | +1.37% | +30.88% | +34.58% | 365.91B | |
| Weighted average by Cap. | -0.26% | +2.19% | +49.22% | +65.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 19.99M 18.73M 17.08M 32.12M 2.2B 32.61M 220M 86.1M 1.1B 86.62M 84.74M 3.67B | 24.22M 20.98M 19.66M 17.93M 33.71M 2.31B 34.23M 231M 90.37M 1.16B 90.92M 88.94M 3.86B |
| Net income | -5.27M -4.56M -4.28M -3.9M -7.33M -502M -7.44M -50.29M -19.66M -252M -19.78M -19.35M -839M | -3.2M -2.78M -2.6M -2.37M -4.46M -305M -4.53M -30.58M -11.95M -153M -12.03M -11.76M -510M |
| Net Debt | 10.2M 8.83M 8.28M 7.55M 14.19M 973M 14.41M 97.36M 38.06M 487M 38.29M 37.45M 1.62B | 11.31M 9.8M 9.18M 8.37M 15.74M 1.08B 15.98M 108M 42.2M 540M 42.45M 41.53M 1.8B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | US$0.4600 | -13.19% | 3,674 |
| 10/08/26 | US$0.5299 | -.--% | 100 |
| 07/08/26 | US$0.5299 | +8.14% | 1,891 |
| 06/08/26 | US$0.4900 | -7.51% | 670 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
